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34A Guide to Studying Human Hair Follicle
Cycling In Vivo
Ji Won Oh1,2,3,4,5, Jennifer Kloepper6, Ewan A. Langan6,7, Yongsoo Kim8, Joongyeub Yeo9, Min Ji Kim10,
Tsai-Ching Hsi3,4,5, Christian Rose11, Ghil Suk Yoon12, Seok-Jong Lee10, John Seykora13,
Jung Chul Kim1,2, Young Kwan Sung2, Moonkyu Kim1,2,16, Ralf Paus14,15,16 and Maksim V. Plikus3,4,5,16Hair follicles (HFs) undergo lifelong cyclical transformations, progressing through stages of rapid growth (ana-
gen), regression (catagen), and relative “quiescence” (telogen). Given that HF cycling abnormalities underlie
many human hair growth disorders, the accurate classification of individual cycle stages within skin biopsies is
clinically important and essential for hair research. For preclinical human hair research purposes, human scalp
skin can be xenografted onto immunocompromisedmice to study humanHF cycling andmanipulate long-lasting
anagen in vivo. Although available for mice, a comprehensive guide on how to recognize different human hair
cycle stages in vivo is lacking. In this article, we present such a guide, which uses objective, well-defined, and
reproducible criteria, and integrates simple morphological indicators with advanced, (immuno)-histochemical
markers. This guide also characterizes human HF cycling in xenografts and highlights the utility of this model for
in vivo hair research. Detailed schematic drawings and representativemicrographs provide examples of howbest
to identify human HF stages, even in suboptimally sectioned tissue, and practical recommendations are given for
designing human-on-mouse hair cycle experiments. Thus, this guide seeks to offer a benchmark for human hair
cycle stage classification, for both hair research experts and newcomers to the field.
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Limitations of the murine hair follicle model
Human and murine hair follicles (HFs) share the same
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Journal of Investigative Dermatology (2016), Volume 136 ª 2015 The Aresearch in mice has long been both the foundation and at
the forefront of our understanding of hair biology (Dry, 1926;
Hsu et al., 2014; Montagna and Ellis, 1958; Plikus and
Chuong, 2014; Schneider et al., 2009; Sundberg et al.,
2005). In both species, HFs contain the same principal cell
types and undergo repetitive cycling, alternating between the
phases of active growth (anagen), regression (catagen), and
relative “quiescence” (telogen) (Geyfman et al., 2014; Paus
and Cotsarelis, 1999; Schneider et al., 2009).
However, significant interspecies differences exist, limiting
the translational potential of the murine HF model. Critically,
anagen in the human scalp lasts for several years, whereas
murine dorsal skin anagen is only 2e3 weeks long (Garza
et al., 2012; Halloy et al., 2000; Mu¨ller-Ro¨ver et al., 2001),
and epithelial HF stem cells differ in their markers and
characteristics (Cotsarelis, 2006; Kloepper et al., 2008; Purba
et al., 2014). Furthermore, whereas murine pelage HFs syn-
chronize their cycles and grow in coordinated domains
(Plikus et al., 2008, 2011), human scalp HFs cycle asyn-
chronously (mosaic, stochastically driven hair cycle)
(Dawber, 1997; Halloy et al., 2000) (see also Supplementary
Text S1 online).
Although both human and murine HFs are exquisitely
responsive to hormonal stimulation, their responses differ.
For example, although estrogens and prolactin inhibit
murine HF growth and cycling, both hormones prolong
anagen duration in human female temporofrontal scalp
HFs (Langan et al., 2010; Ohnemus et al., 2006). Thus, the
response of murine HFs to stimulation with candidate hair
growth-modulating agents does not necessarily predict how
human HFs will respond, and may actually be misleading.
Finally, the characteristic phenomenon of androgen-
dependent HF miniaturization, seen in androgeneticuthors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.
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not reproducible in the currently available mouse strains
(Crabtree et al., 2010; Nakamura et al., 2013; Sundberg
et al., 1999).
The clinical importance of standardized human hair cycle
staging
Considering that scalp skin harbors approximately 100,000
terminal HFs, even minor variations in their cycling have
major clinical effects (Dawber, 1997). Thus, a small increase
in the percentage of telogen scalp HFs by just a few percent
can cause substantial effluvium, for example, because of
premature catagen induction by hormones, inflammatory
mediators, neuropeptides, autoimmune reactions, cytotoxic
drugs, psychoemotional stress, or malnutrition (reviewed in
Atanaskova Mesinkovska and Bergfeld, 2013; Dawber, 1997;
Paus, 2006; Paus and Cotsarelis, 1999; Paus and Foitzik,
2004; Paus et al., 2013; Shapiro, 2007). Moreover, estab-
lishing an accurate anagen-to-catagen-to-telogen HF ratio is
important for diagnosing the kind of alopecia at hand and for
assessing its severity and progression. Although the telogen-
to-anagen ratio can be determined noninvasively via a pho-
totrichogram, skin biopsies and histological staging are
required to identify catagen HFs and to distinguish defined
anagen substages (Van Neste, 2002). Additionally, accurate
histological hair cycle stage assessment is essential for
quantitative preclinical and clinical hair research.
Therefore, an easy-to-follow objective guide for the pre-
cise, standardized, and reproducible identification of human
HF cycle stages is needed, ideally on the basis of routine
histochemistry alone, without having to examine stage-
specific molecular markers by immunohistochemistry,
unless the latter provides crucial, otherwise unobtainable,
insights. Although a comprehensive guide for murine hair
cycle staging has long been available (Mu¨ller-Ro¨ver et al.,
2001), the only major review on the human hair cycle
dates back to 1959 (Kligman, 1959), yet it provides insuffi-
cient detail to guide accurate hair cycle staging. Although this
review has since been complemented by excellent atlases
(e.g., Sperling et al., 2012; Whiting, 2004), and by a guide for
evaluating the anagen-catagen transition of microdissected,
organ-cultured human HFs ex vivo (Kloepper et al., 2010), a
standardized, comprehensive, user-friendly, and electroni-
cally accessible human hair cycle guide in vivo is missing.
This study strives to provide this.
Standardized assessment of human HF cycling in the
xenograft mouse model
HF xenotransplantation is currently the only preclinical assay
that permits complete human HF cycling and supports long-
lasting human anagen studies in vivo. Therefore, it is a
uniquely instructive and indispensable human hair research
tool. However, despite several early reports (De Brouwer
et al., 1997; Gilhar et al., 1988, 1998; Hashimoto et al.,
2000, 2001; Jahoda et al., 1996; Krajcik et al., 2003; Lyle
et al., 1999; Tang et al., 2002; Van Neste et al., 1989), and
more recent uses for the experimental induction of alopecia
areata (Gilhar et al., 2013), postgrafting human scalp hair
cycle dynamics remain poorly characterized, hindering
broader adaptation of this model. Furthermore, as
xenografting is inevitably associated with surgery-, woundhealing-, reinnervation-, and reperfusion-related phenomena
that are absent during normal scalp HF cycling in vivo (see
below), a detailed morphological comparison between xen-
ografted and freshly biopsied human scalp HFs is needed.
Because such a comparison has previously been unavailable,
there is limited understanding of the extent to which human
hair cycle events seen in xenotransplants are representative of
normal human hair cycle progression in vivo.
Therefore, this human hair cycle guide is complemented
with a systematic analysis of HF cycling in xenografted hu-
man scalp skin, noting major similarities alongside minor
differences and specific transplantation-related phenomena
that one needs to be aware of. Finally, we report statistically
validated, practical recommendations for designing human-
on-mouse HF xenotransplantation experiments.
RESULTS
Human hair cycle staging
HF cycle stages were evaluated based on the following his-
tological characteristics (Supplementary Table S1): (i) size
and shape of the dermal papilla (DP) and hair matrix, (ii)
epithelial outer root sheath (ORS) morphology, (iii) connec-
tive tissue sheath (CTS) and vitreous membrane morphology,
(iv) hair shaft characteristics, such as length and the presence
of club hair, (v) the presence of the inner root sheath (IRS), (vi)
pigment distribution, and (vii) the presence of apoptotic and/
or proliferating cells, following the example of murine hair
cycle staging (Mu¨ller-Ro¨ver et al., 2001). Additional markers
can be assessed immunohistologically to demarcate selected
cell populations or structures, such as epithelial stem cells or
HF-associated keratins, but are dispensable for hair cycle
staging (Supplementary Table S2 online).
Similar to routine hair transplantation in humans (Unger,
2005) or in chemotherapy-induced alopecia (Hendrix et al.,
2005; Paus et al., 2013), xenografted anagen HFs (HFs-XG)
predominantly enter catagen, thereby inducing a new hair
cycle and allowing for quick recovery from surgery-
associated damage. Whereas these HFs-XG often show
signs of dystrophy (“dystrophic catagen”), less damaged HFs-
XG enter into the “dystrophic anagen” damage-response
pathway, with retarded progression into a new hair cycle
(Paus et al., 2013). In the following sections, we first describe
HF morphology in human scalp skin in situ (HFs-IS) and
subsequently explain the extent to which the hair cycle stages
of HFs-XG recapitulate HFs-IS. Importantly, when staging
HFs-IS, HF size and position relative to neighboring follicles
and to epidermal/dermal or dermal/adipose tissue boundaries
can be used as morphological landmarks. However, these
landmarks cannot be recruited for hair cycle staging of
HFs-XG, especially if follicular units (Unger, 2005) are
transplanted.
Early catagen
This guide covers catagen first because after human HFs
complete their fetal morphogenesis (Montagna and Ellis,
1958), their lifelong cycling activity begins with the first
catagen entry in utero. For practical reasons, the eight distinct
stages of catagen development in mice (Mu¨ller-Ro¨ver et al.,
2001) are best subdivided into three relatively easily recog-
nizable stages (Kloepper et al., 2010): “early catagen,”www.jidonline.org 35
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36equivalent to murine catagen phases IeIV; “mid-catagen”
(i.e., murine catagen VeVI); and “late catagen” (i.e., murine
catagen VIIeVIII) (Mu¨ller-Ro¨ver et al., 2001).
In HFs-IS, matrix and DP volume reduction, together with
a complete cessation of HF pigmentation, are the earliest
signs of catagen development that can be positively distin-
guished from anagen stage VI. Characteristically, the DP
becomes more condensed and almond-shaped. Termination
of melanogenesis (Bodo et al., 2007; Slominski et al., 2005;
Tobin, 2011) results in the proximal end of the hair shaft
becoming notably less pigmented than in anagen VI HFs
(Figure 1a). Some melanin incontinence into the DP can
also be seen, as the normal transfer of melanosomes into
precortical hair matrix keratinocytes is interrupted (Tobin,
2011) (Figure 1b, feature #5). Importantly, the morphology
of the bulge region and the overall follicle length remain
largely unchanged compared with anagen VI HFs-IS, and the
lower HF portion rests below the dermal/adipose junction.
Positive staining for apoptotic cells (e.g., by activated
caspase-3 or TUNEL immunofluorescence) in the regressing
epithelium above the DP can be used as a definitive immu-
nohistological marker of early catagen, because apoptotic
cells are essentially undetectable in healthy anagen VI HFs
in vivo (Botchkareva et al., 2006, 2007; Sharova et al., 2014).
Furthermore, the downregulation of IRS and DP immunohis-
tological markers can be used to differentiate early-catagen
HFs from anagen VI HFs (see Supplementary Table S2)
(Commo andBernard, 1997;Malgouries et al., 2008a, 2008b).
In HFs-XG, anagen VI progresses into catagen unusually
rapidly so that on day 2 after grafting, follicles that closely
correspond to murine catagen stage IV (Mu¨ller-Ro¨ver et al.,
2001) can already be found (Figure 1deh). In catagen
HFs-XG, thematrix is reduced down to just 2e3 cell layers, yet
still envelops a small, almond-shaped DP (Figure 1f and g,
feature #2). The newly forming club hair is located a short
distance above the condensedDP (Figure 1f and g, feature #6).
A significant portion (76.4%) of HFs-XG undergo “dystro-
phic catagen” (Paus et al., 2013), during which a normal,
serrated club hair shaft fails to form. In addition, the regressing
hair matrix above the DP commonly contains ectopic melanin
deposits (Supplementary Figures S1aee and S3 online).
Mid-catagen
In HFs-IS and HFs-XG, the matrix and DP further decrease in
volume; residual matrix is only 1e2 cell layers thick and only
partially wraps around the condensed, almond-shaped DP
(Figure 1i, features #1 and #2). A brush-like club hair be-
comes prominent at this stage, and it resides above the
dermal/adipose boundary (Figure 1i and p, feature #4). The
newly formed epithelial strand (the remnant of the regressing
hair matrix and proximal ORS) between the club hair and the
DP is thin, generally lacks pigment, and can have a ruffled,
zipper-like appearance (Figure 1i, o, and p, feature #3).
Compared with early-catagen, mid-catagen HFs acquire
visible thickening of the vitreous membrane of the CTS,
which prominently stains for the glycoprotein, biglycan
(Figure 1i, o, and q, feature #5). Because the IRS regresses
and disappears during catagen, its absence can be used to
differentiate mid- to late-catagen HFs from early-anagen III
HFs on hematoxylin and eosin stained sections (Commo andJournal of Investigative Dermatology (2016), Volume 136Bernard, 1997). Dystrophic mid-catagen HFs-XG either lack
or have incompletely formed club hairs, and in these HFs
melanin clumps and vitreous membrane thickening are
prominent (Supplementary Figures S1fej and S3).
Late catagen
In both HFs-IS and HFs-XG, the matrix disappears, and the DP
becomes condensed and ball-shaped (Figure 1r and y, feature
#1). The club hair is now prominently visible (Figure 1r and z,
feature #4), and the epithelial strand is shortened (to about
half the length of that of mid-catagen HFs) (Figure 1r, x, and y,
feature #3). The thickened CTS, which characteristically trails
below the DP into the adipose tissue in HFs-IS and can
contain melanin clumps (in HFs-XG), becomes prominent at
this stage (“dermal streamer”) (Figure 1r, feature #5). A few
apoptotic cells can still be detected in the epithelial strand
(Figure 1t, feature #6). Importantly, in late catagen, apoptotic
cells can also be found in the shrinking sebaceous gland
(Figure 1t, feature #7), like in mice (Lindner et al., 1997).
Dystrophic late catagen HFs-XG display ectopic melanin
deposition in the epithelium (Supplementary Figures S1keo
and S3) and prominent pleats in the bulge region (Figure
1x, feature #8), which colocalize with CD200-positive
epithelial progenitors (Figure 1z) (Purba et al., 2014).
Telogen
HFs with typical telogen morphology can be seen in situ, but
are generally absent in xenografts. Their defining character-
istics are: (i) positioning of the HF entirely above the dermal/
adipose boundary (Figure 2a, feature #4), (ii) prominent
unpigmented, serrated club hair (Figure 2a, feature #3), and
(iii) very compact, well-rounded DP separated from the club
hair by a maximally shortened, unpigmented epithelial
strand, the “secondary hair germ” (Figure 2a, features #1 and
#2). Apoptotic cells are generally not observed (Figure 2c,
feature #5).
However, consistent with previous reports (reviewed in
Geyfman et al., 2014), a few dispersed (not clustered)
proliferating cells can often be seen in the secondary hair
germ and the distal epithelium of telogen HFs-IS (Figure 2c,
feature #6). Thus, telogen HFs are not really “resting.” Un-
fortunately, the functionally crucial distinction between “re-
fractory” and “competent” telogen HFs is not possible by
histology, and the corresponding molecular signatures have
only been characterized for murine telogen (see Geyfman
et al., 2014). Importantly, human telogen HFs-IS can un-
dergo exogen, the phase of active club hair shedding (Higgins
et al., 2009; Stenn, 2005). Following exogen, HFs-IS enter
kenogen, the telogen phase without the presence of a club
hair (Rebora and Guarrera, 2002), which can last for several
months (Courtois et al., 1994).
Anagen I
Because of their relatively short duration, early stages of
anagen can be quite difficult to identify in situ. One also
needs to keep in mind that hair cycle staging describes a
continuous and dynamic morphogenetic process in a
discontinuous manner (only anagen VI and telogen are rela-
tively stable stages; for detailed discussion, see Bernard,
2012). Unlike in scalp skin, anagen I is relatively common
in xenografts, making this themodel of choice for investigating
Figure 1. Catagen. For practical reasons, catagen was subdivided into three easily recognizable stages: early, mid-, and late catagen. For each stage, a schematic
drawing is provided, with key features numbered and marked. For HFs-IS, 5e10% of all HFs are in catagen. In xenografts, approximately three quarters of HFs-
XG undergo “dystrophic catagen,” during which a club hair fails to form (see Supplementary Figure S1). (aeh) Early catagen in HFs-IS (aec0) and HFs-XG (deh).
Key features at this stage are hair matrix volume loss, absence of pigment at the proximal end of the hair shaft, melanin incontinence into the DP, and the
appearance of apoptotic cells. On in situ, HF length remains unchanged compared with anagen VI HFs. In xenografts, the peak day for early catagen is
postgrafting day 3. (ieq) Mid-catagen in HFs-IS (iel) and HFs-XG (meq). Key features at this stage are a shrinking hair matrix, which is only 1e2 cell layers thick,
thin epithelial strand with pleated outlines and apoptotic cells, presence of the brush-like club hair, and a thick vitreous membrane. In scalp skin, the proximal
portion of the HF is still within the adipose layer. In xenografts, the peak day for mid-catagen is postgrafting day 18. (rez) Late catagen in HFs-IS (reu) and HFs-
XG (vez). Key features at this stage are a smaller, ball-shaped DP, absence of the hair matrix, shortened epithelial strand (compared to mid-catagen), prominent
connective tissue sheath with the trail below the DP, melanin clumps in the trail, and ongoing apoptosis in the epithelial strand. Additionally, apoptosis
occurs in the sebaceous gland in HFs-IS. In xenografts, the bulge region develops prominent pleats. This stage peaks on postgrafting day 29. Hosts: SCID mice
(panels e, g, m, q, x, y), nude mice (panels d, f, h, n, o, p, v, w, z). Immunostaining markers: h - activated caspase 3 (red), q - biglycan (red), k, t - TUNEL
(green)/Ki67 (red), z - CD200 (green)/Ki67 (red). CTS, connective tissue sheath; DP, dermal papilla; HFs, hair follicles; HFs-IS, hair follicle morphology in human
scalp skin in situ; HFs-XG, xenografted anagen hair follicles; IRS, inner root sheath; ORS, outer root sheath; SCID, severe combined immunodeficiency.
Scale bars: 100 mm.
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Figure 2. Telogen and anagen I, II. (aed) Telogen. HFs with typical telogen morphology represent 1e2% of all HFs on in situ findings and are generally lacking
in xenografts. Key features at this stage are a very small DP and a short secondary hair germ that lacks apoptotic cells. The entire length of the telogen HF rests in
the dermis. (eej) Anagen I. HFs with anagen I morphology are generally not found in situ but are common in xenografts, peaking on postgrafting day 33. Key
features at this stage are a small DP, a secondary hair germ shaped as a triangle or a small crescent, and an initiation of proliferation at the base of the germ. (ket)
Anagen II in HFs-IS (ken) and HFs-XG (oet). Key features at this stage are a small DP with a wide stalk (compared with telogen and anagen I), an enlarged
secondary hair germ with prominent crescent shape, and a localized proliferation hotspot at the base of the germ. On in situ, the entire length of the HF rests in
the dermis. In xenografts, the peak day for anagen II is postgrafting day 40. Hosts: SCID mice (panels f, g, h, j, o, q, r, s), nude mice (panels e, i, p, t).
Immunostaining markers: c, m - TUNEL (green)/Ki67 (red), j - cytokeratin 15 (red), t - CD200 (green)/Ki67 (red). CH, club hair; CTS, connective tissue sheath; DP,
dermal papilla; HFs, hair follicles; HFs-IS, hair follicle morphology in human scalp skin in situ; HFs-XG, xenografted anagen hair follicles; IRS, inner root sheath;
ORS, outer root sheath; SCID, severe combined immunodeficiency; SHG, secondary hair germ. Scale bars: 100 mm.
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38the human telogen-to-anagen transformation. Anagen I HFs-
XG display a hybrid morphology: (i) similar to late catagen,
their bulge region’s epithelium retains a pleated appearance
(Figure 2g, feature #8); (ii) the secondary hair germ becomes
triangular or crescent-shaped and wraps around the DP
(Figure 2gei, feature #7), which remains condensed and ball-
like. DP may contain melanin clumps (i.e., pigment residue
from the preceding anagen VI stage) (Figure 2i, feature #9),
and still shows a CTS trail (Figure 2h, feature #1).
Anagen II
In HFs-IS and HFs-XG, the secondary hair germ under-
goes proliferation-driven thickening and elongation
(Figure 2ket). Its proximal end develops into a new hair
matrix that at this stage is still unpigmented, crescent-
shaped, and only partially encloses a small, yet slightly
larger and less densely packed, ball-shaped DP (Figure 2k
and qes, features #1 and #2). Proliferation markers reveal
localized clusters of dividing cells in the thickened hairJournal of Investigative Dermatology (2016), Volume 136germ (Figure 2m, feature #4), whereas apoptotic cells are
lacking. The entire length of stage II anagen HFs-IS resides
above the dermal/adipose boundary. In HFs-XG, the bulge
region’s epithelium retains its pleated appearance (Figure 2r
and t, feature #6), and the DP still contains melanin deposits
(Figure 2s, feature #5).
Anagen III
In both HFs-IS and HFs-XG, the hair matrix has now formed
and is 4e5 cell layers thick. It encloses at least 60% of the
DP, which becomes enlarged and oval-shaped (Figure 3a and
gek, feature #2). Prominently, at this stage, HFs develop a
hair shaft and an IRS, both of which are easily identifiable in
routine hematoxylin and eosin stains (Figure 3a, b, g, i, and k,
feature #3). Immunostaining for proliferation markers reveals
actively dividing cells both in the hair matrix and in the ORS
(Figure 3c and j, feature #5). In situ, the hair bulb now rea-
ches and extends into the adipose layer. In both HFs-IS and
HFs-XG, three anagen III substages can be differentiated
Figure 3. Anagen III. Key features at this stage are an enlarged, oval-shaped DP (compared with anagen II), the presence of a newly formed, albeit small hair
matrix (4e5 cell layers thick), small, but visible IRS, and a hair shaft that lacks pigmentation. On in situ, a newly formed hair bulb enters into the adipose layer.
Three anagen III substages can be identified on the basis of combined IRS and hair shaft morphology. The bulge region of HFs-XG shows prominent pleats. This
stage peaks on postgrafting day 47. Hosts: SCID mice (panels f, h, j), nude mice (panels e, g, i, k). Immunostaining markers: c - TUNEL (green)/Ki67 (red), h -
Ki67 (green)/CD200 (red), j - Ki67 (green). CTS, connective tissue sheath; DP, dermal papilla; HFs, hair follicles; HFs-IS, hair follicle morphology in human scalp
skin in situ; HFs-XG, xenografted anagen hair follicles; IRS, inner root sheath; ORS, outer root sheath; SCID, severe combined immunodeficiency. Scale bars:
100 mm.
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visible cortex (Figure 3g). Anagen IIIb and IIIc shafts have a
visible cortex, whereas anagen IIIc hair shafts are long,
reaching approximately twice the length of the hair matrix
(Figure 3k). Importantly, throughout anagen III, hair shafts still
lack visible pigmentation, even though HF melanogenesis in
the HF pigmentary unit commences in anagen IIIc (Slominski
et al., 2005). Last, the bulge epithelium of HFs-XG retains a
pleated appearance (Figure 3i and k, feature #6), and the DP
still contains occasional melanin clumps.
Anagen IV
At this stage, the hair shaft is fully mature, with a distinct
medulla (in terminal HFs), cortex, and cuticle easily identi-
fiable on hematoxylin and eosin stained sections, and the
hair tip reaches the level of the sebaceous gland duct
(Figure 4aeh, feature #5). Importantly, melanin production
and transfer are now fully reactivated, and hair shafts become
visibly pigmented. In situ, the hair bulb now reaches down to
the upper dermal adipose layer (Figure 4a, feature #2), and a
distinct CTS trail is visible proximal to the bulb, which guides
further HF downgrowth (Figure 4a, feature #7).
Anagen V
In situ, the hair bulb extends further into the adipose layer,
and the CTS trail disappears at this stage (Figure 4i, feature
#2). In both HFs-IS and HFs-XG, the tip of the hair shaft entersthe hair canal (Figure 4i, j, and k, feature #5). The DP is now
onion-shaped, and in the hair matrix, pigmentation reaches
down to Auber’s line (Figure 4l and m, features #1, #2, and
#6). Additionally, in HFs-XG, bulge epithelium contours
begin to smoothen (Figure 4l, feature #8).
Anagen VI
The vast majority of scalp HFs in situ are in anagen stage VI.
The hair bulb is located deep in the dermal adipose layer,
whereas the hair shaft emerges above the skin level
(Figure 4pew). In pigmented HFs, the hair matrix contains the
maximum amount of melanin, which now reaches below
Auber’s line. In HFs-XG, bulge epithelium smoothens, but
residual undulations, which may be homologous to the
“follicular trochanter” inHFs-IS (Tiede et al., 2007), can persist
(Figure 4u, feature #8). Compared with anagen V, the DP is
maximally extended and enriched in extracellular matrix.
Practical recommendations for the xenograft model
Long-term survival of individually grafted human scalp
HFs is much more consistent in severe combined immuno-
deficiency (SCID) mice, averaging between 55% and 67%
(Supplementary Figure S6d online). In nude mice, it was
extremely variable, ranging from 0% to 82%, likely reflecting
mouse-to-mouse variability in graft rejection (Supplementary
Figure S4 online). Also, among actively cycling HFs-XG,
average hair growth rates are faster and more consistent inwww.jidonline.org 39
Figure 4. Anagen IV, V, and VI. (aeh) Anagen IV in HFs-IS (a, b) and HFs-XG (ceh). Key features at this stage are a prominent matrix, stratified ORS, and a
mature hair shaft that reaches the level of the sebaceous gland. On in situ, the hair bulb is in the adipose layer, but the connective tissue trail can still be seen (it
becomes lost during anagen V). HFs-XG IV show prominent pleats in the bulge region and peak on postgrafting day 60. (ieo) Anagen V in HFs-IS (i) and HFs-XG
(jeo). Key features at this stage are a large onion-shaped DP, significantly increased pigmentation (compared with anagen IV) with sharp demarcation at Auber’s
line, and a mature hair shaft that reaches the hair canal. On in situ, the connective tissue trail disappears (compared with anagen IV). HFs-XG V maintain pleats
in the bulge region and peak on postgrafting day 63. (pew) Anagen VI in HFs-IS (per) and HFs-XG (sew). A total of 90e95% of all HFs-IS are in anagen VI, and
all HFs-XG progress to anagen VI by postgrafting day 92. At this stage, HFs achieve their maximum size, and the hair shaft tip extends far above the skin surface.
There are no apoptotic cells compared with early catagen. Hosts: SCID mice (panels e, f, g, m, n, s, t, u, w), nude mice (panels c, d, h, j, k, l, o, v).
Immunostaining markers: h, w - Ki67 (green)/alpha smooth muscle actin (red), o - Ki67 (red), r - TUNEL (green)/Ki67 (red). CTS, connective tissue sheath; DP,
dermal papilla; HFs, hair follicles; HFs-IS, hair follicle morphology in human scalp skin in situ; HFs-XG, xenografted anagen hair follicles; IRS, inner root sheath;
ORS, outer root sheath; SCID, severe combined immunodeficiency. Scale bars: 100 mm.
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confirms that SCID mice are the host of choice for xeno-
grafted human scalp HFs (Gilhar et al., 1998, 2013).Journal of Investigative Dermatology (2016), Volume 136Xenograft transplantation provides a strong stimulus for
catagen induction, thereby partially synchronizing hair
cycling behavior (Figure 5). However, significant hair cycle
Figure 5. Xenograft model optimization. (a) Representative gross morphology of human HFs-XG showing postgrafted hair cycle resetting dynamics: follicles
progress through sequential catagen substages, telogen-to-anagen transition stage, and then anagen substages. (b, c) Representative images showing hair cycle
heterogeneity of HFs-XG at days 54 (b) and 70 (c). (d) Comprehensive hair cycle staging of human HFs-XG during the first 90 days (x-axis). Average time point
values for each substage (y-axis) are shown with the average regression curve overlaid over the scatter plot of individual HF stage values (assessed on biopsy;
each dot represents one biopsied HF). (e) Statistical analysis of the frequency at which the indicated stage appears (early catagen, telogen-to-anagen I transition,
and anagen III). The arrows denote the postgrafting time with the greatest probability of selecting HFs-XG at the indicated stage based on the naı¨ve Bayes
classifier analysis. Further details (for every hair cycle substage) can be found in Supplementary Figure S5. Hosts: SCID mice (panels a [days 15, 22, 50, 57, 65]
and c), nude mice (panels a [days 4, 8, 30, 36, 45, 71, 77, 120] and b). HFs, hair follicles; HFs-XG, xenografted anagen HFs; SCID, severe combined
immunodeficiency. Scale bars: a, b, c—1 mm.
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points (Figure 5b, c, and d), demonstrating that the mosaicism
of human HF cycling is partially maintained even after
transplantation. We recommend using statistically adjusted
peak time points generated here (see Figure 5e;
Supplementary Figure S5 online) to evaluate the postgrafting
human hair cycle. Moreover, because the majority of HFs-XG
enter anagen stage VI on day 92, studies on anagen should be
performed after this time point.
DISCUSSION
Here, we provide a guide for staging terminal human scalp
HFs in situ and in xenografts (Supplementary Figure S2
online) on the basis of a minimal set of characteristics,identifiable by routine histology. Depending on the specific
hair research question(s) asked, additional standard readout
parameters can be employed that make the analysis of
human HFs even more instructive, and Supplementary
Table S2 lists selected examples for further guidance,
including human HF epithelial progenitor markers (Purba
et al., 2014, 2015).
The mouse xenotransplant model remains indispensable
for studying and experimentally manipulating human HF
cycling in vivo. Besides follicular unit transplantation, as in
the current study, one can also transplant carefully trimmed
full-thickness scalp skin (Gilhar et al., 1998, 2013; Sintov
et al., 2000; Van Neste et al., 1989). This greatly reduces
the level of surgery-related damage suffered by HFs locatedwww.jidonline.org 41
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42away from the transplant edge and has the added advantage
of permitting one to study the cycling behavior of an entire
HF field as well as terminal HFs alongside vellus HFs, com-
plete with associated sebaceous and sweat glands. However,
perfusion, oxygenation, and reinnervation can be precarious
in the center of such full-thickness transplants.
When interpreting data obtained with the xenotransplant
model, one must keep in mind a number of confounding
factors that may influence the results profoundly. Namely,
xenotransplanted human HFs are reperfused and reinnervated
by cells and structures derived from an alien host, and are
shock-exposed to and must rapidly adjust to the foreign
endocrine, innate immune, and metabolic systems of SCID
mice. In addition, the murine host launches a stress response
to the trauma of surgery (note that perceived stress in mice
triggers substantial perifollicular neurogenic inflammation,
which is NGF-, substance P-, and mast cell-dependent, cen-
ters around the bulge, and prematurely induces catagen in
murine anagen HFs (Arck et al., 2005). Coupled with the fact
that human scalp HFs also respond to key stress mediators
(reviewed in Paus et al., 2014), all of these confounding factors
are expected to impact greatly on human HF cycling, growth,
immune status, pigmentation, and metabolism in vivo after
xenotransplantation. Therefore, caution is advised in extrap-
olating from observations made with human HF xenotrans-
plants in mice to the response of healthy human scalp skin.
At any given time, the vast majority of asynchronously
cycling HFs in healthy human scalp are considered to be in
anagen (80e90%), between 10% and 20% in telogen, and
only 1e5% in catagen (Dawber, 1997; Shapiro, 2007;
Sperling et al., 2012; Whiting, 2004). However, our current
histological analysis of HFs-IS suggests that the number of
catagen HFs can exceed that of telogen HFs (catagen:
5e10%, telogen: 1e2%). This discrepancy likely reflects
differences in assessment methodologies, because photo-
trichograms cannot distinguish between telogen and catagen
and are thus less accurate compared with histology-based
hair cycle staging (Hoffmann, 2001; Van Neste and Trueb,
2006). Additional histomorphometric hair cycle staging will
be required to refine the true anagen-to-catagen-to-telogen
scalp HF ratio.
Because of the relatively short duration of anagen IeV,
these anagen stages are rarely found in situ, with the notable
exception of the weeks after extensive telogen effluvium,
when a surge in premature anagen termination is followed by
semisynchronous anagen reactivation (Hadshiew et al.,
2004; Harrison and Sinclair, 2002; Katz et al., 2006). Thus,
an unusually high percentage of anagen stage IeV HFs points
toward a preceding telogen effluvium.
Unlike in situ, anagen IeV HFs can be readily identified in
xenografts due to a telogen effluvium-like resetting effect
from the traumatic transplantation procedure (Gilhar et al.,
1988; Hashimoto et al., 2000, 2001; Jahoda et al., 1996;
Van Neste et al., 1989), complicated by various degrees of
HF dystrophy, just as after chemotherapy (Paus et al., 1994,
2013). This resetting, however, is incomplete. Although in-
dividual xenotransplanted anagen HFs rapidly enter catagen
by day 3, their progression through catagen is variable, and
late-catagen HFs can still be found on day 50. This likely
reflects a variable response to trauma, when some HFs enterJournal of Investigative Dermatology (2016), Volume 136into normal, but premature, catagen or the “dystrophic
catagen,” whereas others undergo a “dystrophic anagen,”
which protracts catagen development (Hendrix et al., 2005;
Paus et al., 2013). This variable timing of the catagen pro-
gram leads to incomplete hair cycle synchronization,
heralding the re-establishment of cycling mosaicism. Addi-
tionally, grafted HFs do not appear to enter long-lasting tel-
ogen, suggesting that the normal HF stem cell quiescence
mechanisms (Geyfman et al., 2014; Mardaryev et al., 2011)
may be altered, perhaps as a result of the confounding, host-
derived factors summarized above.
SCID mouse xenotransplantation model optimization for
studying human anagen
Despite limitations of the xenograft model, HFs-XG closely
resemble cycling HFs-IS and are able to enter long-lasting
anagen. Therefore, the SCID mouse xenograft model
(see also Gilhar et al., 1998, 2013) provides an extremely
valuable experimental system for investigating multiple,
otherwise difficult-to-study aspects of human HF biology, and
instructively complements in vitro human HF and scalp skin
organ culture (Al-Nuaimi et al., 2014; Hardman et al., 2015;
Kloepper et al., 2010; Langan et al., 2015; Lu et al., 2007; Oh
et al., 2013; Philpott et al., 1990; Poeggeler et al., 2010). We
recommend using at least three postgrafting time points to
study catagen-to-anagen progression, and waiting until after
postgrafting 92 days for studying anagen VI HFs. This is
substantially later than the postgrafting day 60e70 reported
previously (Hashimoto et al., 2000, 2001). Future studies
wishing to investigate human HF responses to hormonal
stimulation, for example, in the context of androgenetic al-
opecia, also need to consider the intricate hormone sensi-
tivity of human HFs (Paus et al., 2014) and their keratin
expression patterns (Ramot and Paus, 2014); therefore,
imitating donor-like hormone levels in host mice (e.g.,
testosterone) is important (De Brouwer et al., 1997; Krajcik
et al., 2003; Sintov et al., 2000; Van Neste et al., 1991).
In summary, although Mus musculus remains unrivaled in
the insights it has helped to generate into basic HF biology,
murine HF physiology is quite different from that of human
HF. The xenotransplant model characterized above, there-
fore, provides an indispensable tool for human preclinical
hair research in vivo, if employed together with the
comprehensive guide for human hair cycle staging developed
here.
MATERIALS AND METHODS
Human scalp hair follicles and xenografting
Institutional approval and written informed patient consent were
received for all studies using human tissue samples, and institutional
approval was received for all animal studies. Human scalp skin in
situ studies were performed on normal occipital and temporal scalp
skin samples following previously published protocols (Harries and
Paus, 2010; Harries et al., 2013; Kloepper et al., 2010). For xeno-
grafting, nonbalding occipital scalp skin specimens were used. The
method for human HF xenografting was adapted after Hashimoto
et al. (2000). Briefly, 15e40 (on average 25) microdissected ana-
gen VI follicular units were transplanted onto 6- to 8-week-old
female nude or SCID mice (Jackson Laboratory, Bar Harbor, ME). A
total of 1,164 HFs were transplanted and then biopsied and
JW Oh et al.
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and Supplementary Materials and Methods online).
Histological tissue analysis
Paraffin embedded HF samples were sectioned at 3 mm thickness,
and OCT compound embedded follicles were sectioned at 8 mm at
e20 C. Sections were processed either for routine histology (he-
matoxylin and eosin staining) or for immunofluorescence staining
(see Supplementary Materials and Methods).
Computational analysis and statistical tests
Hair cycle stage’s mean date was determined by averaging the time
points when biopsied HFs were at the corresponding stage. To es-
timate the time point with the greatest probability of selecting a HF
in the desired stage, the naı¨ve Bayes classifier (Mitchell, 1997) was
used. Additional computer simulations were employed to
derive probability values for each hair cycle stage, and a two-sample
Kolmogorov-Smirnov test (Conover, 1999) was utilized to compare
the speed of HFs-XG hair cycle progression between nude and SCID
host mice (see Supplementary Materials and Methods for details).
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